Okada Ken-ichi, Imaizumi Toshihide, Yazawa Naoki, Matsuyama Masahiro, Dowaki Shoichi, Tobita Kosuke, Hirabayashi Kenichi, Makuuchi Hiroyasu
Department of Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.
Tokai J Exp Clin Med. 2009 Jul 20;34(2):53-7.
Pancreatic cancer is considered resectable only when there are no distant metastases or infiltration of surrounding organs or arteries. We describe a patient with primarily inoperable locally advanced pancreatic adenocarcinoma who underwent curative surgical treatment after preoperative chemotherapy. A 61-year-old woman was admitted for further evaluation of a pancreatic head mass discovered fortuitously on a health screening. Examination revealed locally advanced pancreatic cancer with infiltration of the superior mesenteric artery. After a partial response was obtained by chemotherapy with gemcitabine (GEM) and S-1, we performed pancreaticoduodenectomy. Microscopically, the main tumor was replaced with fibrotic tissue, and there were only a few residual adenocarcinoma cells in the pancreatic head. The radicality of the surgery was R0, according to the TNM classification. Our results suggest that neoadjuvant treatment with GEM/S-1 on a sustainable regimen offers the possibility of a multimodal treatment concept for all patients and a higher radical-resection rate in patients with otherwise unresectable pancreatic cancers.
仅当不存在远处转移或周围器官或动脉未受浸润时,胰腺癌才被认为是可切除的。我们描述了一名最初无法手术的局部晚期胰腺腺癌患者,该患者在术前化疗后接受了根治性手术治疗。一名61岁女性因在健康筛查中偶然发现胰头肿块而入院进一步评估。检查发现为局部晚期胰腺癌,伴有肠系膜上动脉浸润。在用吉西他滨(GEM)和S-1化疗获得部分缓解后,我们进行了胰十二指肠切除术。显微镜下,主要肿瘤被纤维组织取代,胰头仅残留少数腺癌细胞。根据TNM分类,手术切缘为R0。我们的结果表明,采用可持续方案的GEM/S-1新辅助治疗为所有患者提供了多模式治疗理念的可能性,并提高了原本无法切除的胰腺癌患者的根治性切除率。